Medicxi Ventures Management’s ObsEva SA Ordinary Shares OBSV Stock Holding History

Medicxi Ventures Management’s Portfolio OBSV Stock Details OBSV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,570,000	Closed	-$944K	–	6
2022 Q2	$2.53M	Hold	1,570,000	–	–	1.05%	6
2022 Q1	$2.37M	Hold	1,570,000	–	–	0.64%	7
2021 Q4	$3.12M	Hold	1,570,000	–	–	0.78%	7
2021 Q3	$4.88M	Hold	1,570,000	–	–	1.06%	6
2021 Q2	$4.76M	Hold	1,570,000	–	–	0.85%	6
2021 Q1	$5.1M	Hold	1,570,000	–	–	2.97%	5
2020 Q4	$3.27M	Hold	1,570,000	–	–	1.9%	5
2020 Q3	$3.89M	Hold	1,570,000	–	–	1.86%	5
2020 Q2	$9.25M	Hold	1,570,000	–	–	5.68%	4
2020 Q1	$3.78M	Hold	1,570,000	–	–	4.94%	3
2019 Q4	$6M	Buy	+1,570,000	New	+$8.16M	3.68%	4

Other funds holding OBSV

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Medicxi Ventures Management's OBSV Position: Q3 2022 in Review

Medicxi Ventures Management sold out of ObsEva SA Ordinary Shares (OBSV) in Q3 2022, closing a stake of 1,570,000 shares — an estimated $944K sold.

Medicxi Ventures Management first reported a position in OBSV in Q4 2019 and held it in 11 quarters. The position peaked at $9.25M in Q2 2020. 34 funds tracked by Wall St. Rank hold OBSV as of Q3 2022.

Medicxi Ventures Management reported no remaining ObsEva SA Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Medicxi Ventures Management sold 1,570,000 ObsEva SA Ordinary Shares shares in Q3 2022, an estimated $944K.
Medicxi Ventures Management first reported a position in ObsEva SA Ordinary Shares in Q4 2019 and held it in 11 quarters.
Medicxi Ventures Management's ObsEva SA Ordinary Shares position peaked at $9.25M in Q2 2020.
34 funds tracked by Wall St. Rank held ObsEva SA Ordinary Shares as of Q3 2022.

Based on Medicxi Ventures Management's 13F filing for Q3 2022, filed 25 Oct 2022.